imexpharm

Imexpharm Maintains Resilient Growth with 8 Percent Profit Increase in First Quarter of 2026 Amidst Market Volatility

Imexpharm Pharmaceutical Joint Stock Company (IMP) has officially released its financial results for the first quarter of 2026, demonstrating a…